| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.09 | 0.06 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.34 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.084 | 0.06 |